CVS Health Corporation (CVS) Stock: Sinks Despite Raising 2026 Earnings Guidance After Q3 Results

TLDR CVS Health stock plunges 12.28% to $80.19 despite stronger third-quarter results. CVS reports $108.4 billion in Q3 revenue, marking 5.4% year-over-year growth. CVS raises its 2026 adjusted earnings outlook to at least $8.20 per share. CVS plans to split its healthcare and retail pharmacy operations by early 2028. CVS Pharmacy will manage about 9,000 [...]

The post CVS Health Corporation (CVS) Stock: Sinks Despite Raising 2026 Earnings Guidance After Q3 Results appeared first on Blockonomi.